|
| | |
| |
Press Release |
| | |
February 5, 2019 | | FOR IMMEDIATE RELEASE |
CTS Announces Fourth Quarter and Full Year 2018 Results
Strong sales and earnings growth
Lisle, Ill. - CTS Corporation (NYSE: CTS) today announced fourth quarter and full year 2018 results.
Fourth Quarter 2018 Results
| |
• | Sales were $120.1 million, up 8.3% year-over-year. Sales to transportation customers increased 7.2%, and sales to other end markets grew 10.2%. |
| |
• | Net earnings were $17.6 million or $0.52 per diluted share. |
| |
• | Adjusted diluted EPS was $0.41 compared to $0.39 in the fourth quarter of 2017. |
Full Year 2018 Results
| |
• | Sales were $470.5 million, up 11.2% compared to 2017. Sales to transportation customers increased 9.0%, and sales to other end markets grew 15.3%. |
| |
• | Net earnings were $46.5 million or $1.39 per diluted share. |
| |
• | Adjusted diluted EPS was $1.53 compared to $1.23 in 2017. |
| |
• | Operating cash flow was $58.2 million. |
| |
• | Total booked business grew $129 million in 2018, a 7.4% increase, to $1.87 billion. |
“We are pleased with our progress in several areas as we transition our business and systems,” said Kieran O’Sullivan, CEO of CTS Corporation. “We are focused on carrying our momentum to continue elevating our performance in the years ahead. We expect growth in medical, telecom, and defense end markets, and remain cautious on industrial and transportation end markets.”
2019 Guidance
Full year 2019 sales are expected to be in the range of $460 to $500 million. Adjusted earnings per diluted share for 2019 are expected to be in the range of $1.50 to $1.70.
Conference Call
As previously announced, the Company has scheduled a conference call at 11:00 a.m. (EST) today to discuss the fourth quarter and full year financial results. The dial-in number is 855-719-5008 (334-323-0517, if calling from outside the U.S.). The passcode is 670352. There will be a replay of the conference call from 2:00 p.m. (EST) today through 2:00 p.m. (EST) on Tuesday, February 19, 2019. The telephone number for the replay is 888-203-1112 (719-457-0820, if calling from outside the U.S.). The replay passcode is 6970679. A live audio webcast of the conference call will be available and can be accessed directly from the Investors section of the website of CTS Corporation at www.ctscorp.com.
About CTS
CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, telecommunications/IT, and transportation markets.
For more information, visit www.ctscorp.com.
Safe Harbor
This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forward-looking statements are based on management's expectations, certain assumptions and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties and other factors, which could cause our actual results, performance or achievements to differ materially from those presented in the forward-looking statements. Many of these, and other, risks and uncertainties are discussed in further detail in Item 1A. of CTS’ Annual Report on Form 10-K. We undertake no obligation to publicly update our forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes.
Contact
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532
USA
Telephone: +1 (630) 577-8800
E-mail: ashish.agrawal@ctscorp.com
###
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (LOSS) - UNAUDITED
(In thousands of dollars, except per share amounts)
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Twelve Months Ended |
| December 31, | | December 31, | | December 31, | | December 31, |
| 2018 | | 2017 | | 2018 | | 2017 |
Net sales | $ | 120,073 |
| | $ | 110,910 |
| | $ | 470,483 |
| | $ | 422,993 |
|
Cost of goods sold | 77,428 |
| | 78,035 |
| | 305,510 |
| | 282,562 |
|
Gross Margin | 42,645 |
| | 32,875 |
| | 164,973 |
| | 140,431 |
|
Selling, general and administrative expenses | 18,128 |
| | 24,973 |
| | 73,569 |
| | 71,943 |
|
Research and development expenses | 5,804 |
| | 6,714 |
| | 25,304 |
| | 25,146 |
|
Restructuring and impairment charges | 1,698 |
| | 1,197 |
| | 5,062 |
| | 4,139 |
|
(Gain) loss on sale of assets | (2 | ) | | 10 |
| | — |
| | 708 |
|
Operating earnings (loss) | 17,017 |
| | (19 | ) | | 61,038 |
| | 38,495 |
|
Other (expense) income: | | | | | |
| | |
|
Interest expense | (484 | ) | | (1,134 | ) | | (2,085 | ) | | (3,343 | ) |
Interest income | 459 |
| | 370 |
| | 1,826 |
| | 1,284 |
|
Other (expense) income | (119 | ) | | 928 |
| | (2,676 | ) | | 3,817 |
|
Total other (expense) income, net | (144 | ) | | 164 |
| | (2,935 | ) | | 1,758 |
|
Earnings before taxes | 16,873 |
| | 145 |
| | 58,103 |
| | 40,253 |
|
Income tax (benefit) expense | (691 | ) | | 13,766 |
| | 11,571 |
| | 25,805 |
|
Net earnings (loss) | $ | 17,564 |
| | $ | (13,621 | ) | | $ | 46,532 |
| | $ | 14,448 |
|
Net earnings (loss) per share: | | | | | |
| | |
|
Basic | $ | 0.53 |
| | $ | (0.41 | ) | | $ | 1.41 |
| | $ | 0.44 |
|
Diluted | $ | 0.52 |
| | $ | (0.41 | ) | | $ | 1.39 |
| | $ | 0.43 |
|
Basic weighted-average common shares outstanding | 32,983 |
| | 32,938 |
| | 33,024 |
| | 32,892 |
|
Effect of dilutive securities | 562 |
| | — |
| | 545 |
| | 528 |
|
Diluted weighted-average common shares outstanding | 33,545 |
| | 32,938 |
| | 33,569 |
| | 33,420 |
|
Cash dividends declared per share | $ | 0.04 |
| | $ | 0.04 |
| | $ | 0.16 |
| | $ | 0.16 |
|
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of dollars)
|
| | | | | | | |
| (Unaudited) | | |
| December 31, | | December 31, |
| 2018 | | 2017 |
ASSETS | |
| | |
|
Current Assets | |
| | |
|
Cash and cash equivalents | $ | 100,933 |
| | $ | 113,572 |
|
Accounts receivable, net | 79,518 |
| | 70,584 |
|
Inventories, net | 43,486 |
| | 36,596 |
|
Other current assets | 15,422 |
| | 12,857 |
|
Total current assets | 239,359 |
| | 233,609 |
|
Property, plant and equipment, net | 99,401 |
| | 88,247 |
|
Other Assets | |
| | |
|
Prepaid pension asset | 54,100 |
| | 57,050 |
|
Goodwill | 71,057 |
| | 71,057 |
|
Other intangible assets, net | 60,180 |
| | 66,943 |
|
Deferred income taxes | 22,201 |
| | 20,694 |
|
Other assets | 2,043 |
| | 2,096 |
|
Total other assets | 209,581 |
| | 217,840 |
|
Total Assets | $ | 548,341 |
| | $ | 539,696 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY | |
| | |
|
Current Liabilities | |
| | |
|
Accounts payable | $ | 51,975 |
| | $ | 49,201 |
|
Accrued payroll and benefits | 14,671 |
| | 11,867 |
|
Accrued expenses and other liabilities | 37,347 |
| | 41,344 |
|
Total current liabilities | 103,993 |
| | 102,412 |
|
Long-term debt | 50,000 |
| | 76,300 |
|
Long-term pension obligations | 6,510 |
| | 7,201 |
|
Deferred income taxes | 3,990 |
| | 3,802 |
|
Other long-term obligations | 5,919 |
| | 6,176 |
|
Total Liabilities | 170,412 |
| | 195,891 |
|
Commitments and Contingencies | | | |
Shareholders' Equity | |
| | |
|
Common stock | 306,697 |
| | 304,777 |
|
Additional contributed capital | 42,820 |
| | 41,084 |
|
Retained earnings | 478,847 |
| | 420,160 |
|
Accumulated other comprehensive loss | (97,739 | ) | | (78,960 | ) |
Total shareholders' equity before treasury stock | 730,625 |
| | 687,061 |
|
Treasury stock | (352,696 | ) | | (343,256 | ) |
Total shareholders' equity | 377,929 |
| | 343,805 |
|
Total Liabilities and Shareholders' Equity | $ | 548,341 |
| | $ | 539,696 |
|
CTS CORPORATION AND SUBSIDIARIES
OTHER SUPPLEMENTAL INFORMATION - UNAUDITED
Earnings Per Share
The following table reconciles GAAP diluted earnings per share to adjusted diluted earnings per share for the Company:
Additional Information
The following table includes other financial information not presented in the preceding financial statements.
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Twelve Months Ended |
| December 31, 2018 | | December 31, 2017 | | December 31, 2018 | | December 31, 2017 |
GAAP diluted earnings per share | $ | 0.52 |
| | $ | (0.41 | ) | | $ | 1.39 |
| | $ | 0.43 |
|
| | | | | | | |
Tax affected charges to reported diluted earnings per share: | | | | | | | |
Restructuring charges | 0.04 |
| | 0.02 |
| | 0.12 |
| | 0.08 |
|
Foreign currency (gain) loss | — |
| | (0.01 | ) | | 0.06 |
| | (0.07 | ) |
Non-recurring costs of tax improvement initiatives | — |
| | — |
| | 0.03 |
| | — |
|
Non-recurring environmental charge | — |
| | — |
| | 0.02 |
| | — |
|
Loss on sale of facilities, net of expenses | — |
| | — |
| | — |
| | 0.01 |
|
Decrease in the recognition of foreign valuation allowance | (0.03 | ) | | (0.01 | ) | | (0.03 | ) | | (0.02 | ) |
Pension settlement charge | — |
| | 0.26 |
| | — |
| | 0.26 |
|
Discrete tax items | (0.10 | ) | | — |
| | (0.04 | ) | | — |
|
Tax impact related to Tax Cuts and Job Acts | (0.02 | ) | | 0.54 |
| | (0.02 | ) | | 0.54 |
|
Adjusted diluted earnings per share | $ | 0.41 |
| | $ | 0.39 |
| | $ | 1.53 |
| | $ | 1.23 |
|
Additional Information
The following table includes other financial information not presented in the preceding financial statements.
|
| | | | | | | | | | | | | | | |
| Three Months Ended | | Twelve Months Ended |
| December 31, 2018 | | December 31, 2017 | | December 31, 2018 | | December 31, 2017 |
Depreciation and amortization expense | $ | 6,165 |
| | $ | 5,613 |
| | $ | 22,514 |
| | $ | 20,674 |
|
Stock-based compensation expense | $ | 1,152 |
| | $ | 1,670 |
| | $ | 5,256 |
| | $ | 4,184 |
|
Non-GAAP Financial Measures
Adjusted earnings per share is a non-GAAP financial measure. The most directly comparable GAAP financial measure is diluted earnings per share.
CTS adjusts for these items because they are discrete events, which have a significant impact on comparable GAAP financial measures and could distort an evaluation of our normal operating performance.
CTS uses an adjusted earnings per share measure to evaluate overall performance, establish plans and perform strategic analysis. Using this measure avoids distortion in the evaluation of operating results by eliminating the impact of events which are not related to normal operating performance. Because this measure is based on the exclusion or inclusion of specific items, they may not be comparable to measures used by other companies which have similar titles. CTS' management compensates for this limitation when performing peer comparisons by evaluating both GAAP and non-GAAP financial measures reported by peer companies. CTS believes that this measure is useful to its management, investors and stakeholders in that it:
| |
• | provides a meaningful measure of CTS' operating performance, |
| |
• | reflects the results used by management in making decisions about the business, and |
| |
• | helps review and project CTS' performance over time. |
We recommend that investors consider both actual and adjusted measures in evaluating the performance of CTS with peer companies.